SPONSOR
Debiopharm International SA
Total Trials
2
Recruiting
2
Phases
Phase 2, Phase 1, Phase 2
Conditions studied: Prostate CancerGlioblastoma IDH (Isocitrate Dehydrogenase) WildtypeAstrocytoma, Grade III
NCT06395753 Phase 2
Recruiting
A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer
Prostate Cancer
NCT05765812 Phase 1, Phase 2
Recruiting
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype